Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mucositis × pegaspargase × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Leukemia 26 Lymphoma 5 Burkitt Lymphoma 5 Recurrence 3 Leukemia, Biphenotypic, Acute 3 Lymphoma, Extranodal NK-T-Cell 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Mucositis 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Immunoproliferative Disorders 1 Fallopian Tube Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Dendritic Cell Sarcoma, Interdigitating 1 Blast Crisis 1

Interventions

Radiotherapy 5 Injections 3 Fibroblast Growth Factor 7 3 Drug Therapy 3 Xylitol 2 Water 2 Propolis 2 Mouthwashes 2 Morphine 2 Methotrexate 2 Melphalan 2 Interleukin 1 Receptor Antagonist Protein 2 Gabapentin 2 Cisplatin 2 peppermint oil 1 pegaspargase 1 oxycodone-acetaminophen 1 nelarabine 1 kang-lai-te 1 glucarpidase 1 fludarabine phosphate 1 fish oil triglycerides 1 cyclohexaneacetic acid 1 calcium phosphate 1 brilacidin 1 anise oil 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 acetaminophen, hydrocodone drug combination 1 Whole-Body Irradiation 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡